| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 6e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.005 |